← Browse by Condition
Medical Condition
uveal melanoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1
NCT06932757 Phase 2
Recruiting
Adjuvant Quisinostat in High-Risk Uveal Melanoma
Enrollment
63 pts
Location
United States
Sponsor
University of Miami
NCT07421739
Recruiting
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Enrollment
15 pts
Location
Australia
Sponsor
Aura Biosciences
NCT04119024 Phase 1
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
NCT07364474
Recruiting
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
Enrollment
10 pts
Location
United States
Sponsor
Massachusetts General Hospital